Biotech
-
8.2KWill The Momentum In BIOC Stock Continue?
BIOC stock is a name that we have covered on and off since 2017. Overall, BIOC stock has been a horrible investment since,...
-
27.2KIBIO Stock: A Key COVID-19 Vaccine Player
The hardest part for investors betting on a coronavirus vaccine is putting all the pieces together. There are more than 400 human...
-
14.2KKTOV Stock About To Squeeze The Shorts
The key with trading penny stocks is to find the momentum BEFORE it happens. We know some are looking at the chart...
-
9.6KIs CODX Stock Heading Back To $30?
CODX stock has been a nice winner this year for our readers and subscribers. We initiated coverage in March when CODX stock...
-
16.6K1XSPA Stock: Buy The Dip
There is a great deal of debate among investors on how best to play the COVID-19 pandemic. Many are betting on a...
-
12.2KWill Moderna Buy ABUS Stock?
An administrative court run by the U.S. Patent and Trademark Office has rejected arguments by Moderna that an ABUS Stock patent known...
-
575TNXP Stock: A Top COVID-19 Vaccine Play
There’s no denying the best sector for investors right now is the COVID-19 vaccine plays. We at Insider Financial have nailed quite...
-
25.1KIs A Buyout Coming In NOVN Stock?
Last month we told our readers and subscribers that NOVN stock was gearing up for a big move when the stock was trading...
-
1.8K1CytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported ...
-
26.9KIs Heat Biologics Stock About To Blast Off?
There’s no denying the best sector for investors right now is the COVID-19 vaccine plays We at Insider Financial have nailed quite...